Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine
R. Menezes Martinsa,1, A.R.S. Périsséb, L.A.B. Camachob, M.L. Lealc, M.L.S. Maiaa, A. Hommad, E. Jessourounc,
Corresponding author
ellen@bio.fiocruz.br

Corresponding author.
a Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
b National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil
c Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
d Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
Read
2151
Times
was read the article
1026
Total PDF
1125
Total HTML
Share statistics
Article information
ISSN: 14138670
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 29 22 51
2024 March 53 21 74
2024 February 43 27 70
2024 January 33 29 62
2023 December 16 34 50
2023 November 23 39 62
2023 October 26 37 63
2023 September 33 37 70
2023 August 15 18 33
2023 July 26 21 47
2023 June 21 12 33
2023 May 39 21 60
2023 April 28 19 47
2023 March 51 26 77
2023 February 34 36 70
2023 January 20 31 51
2022 December 42 50 92
2022 November 48 34 82
2022 October 45 27 72
2022 September 30 57 87
2022 August 24 38 62
2022 July 25 38 63
2022 June 76 39 115
2022 May 38 32 70
2022 April 28 44 72
2022 March 60 54 114
2022 February 66 52 118
2022 January 67 45 112
2021 December 70 69 139
2021 November 16 17 33
Show all

Follow this link to access the full text of the article

The Brazilian Journal of Infectious Diseases